• Study on Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis and Suboptimal Response to Ruxolitinib

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Croatia Czechia France Germany +7

  • Study on the Effects of Finerenone and SGLT2 Inhibitors on Heart and Kidney Health in Patients with Type 2 Diabetes and Chronic Kidney Disease

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark

  • Study on Baricitinib for Patients with Calcium Pyrophosphate Deposition Disease (CPPD) Using Methotrexate Sodium and Drug Combination

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Italy

  • Study on Tranexamic Acid to Prevent Blood Loss in Women with Placenta Previa Undergoing Cesarean Delivery

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study of Atezolizumab and Chemotherapy for Patients with Relapsed Small Cell Lung Cancer

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy

  • Study on Muscle Relaxation Reappearance in Patients Under General Anesthesia Using Glycopyrronium Bromide and Neostigmine Methylsulfate

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Finland

  • Study Comparing Cyclophosphamide, Azathioprine, and Tacrolimus for Patients with Antisynthetase Syndrome-Related Interstitial Lung Disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France

  • Study on the Effects of Dapagliflozin on Kidney Health in Patients with Chronic Kidney Disease After Kidney Transplantation

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on Atezolizumab with FOLFOX for Stage III Colon Cancer with Deficient DNA Mismatch Repair

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study on the Safety and Effectiveness of CABA-201, Fludarabine Phosphate, and Cyclophosphamide in Patients with Active Systemic Lupus Erythematosus

    Recruiting

    2 1 1 1
    Investigated Drugs:
    France Spain

powered by